Research and Markets (http://www.researchandmarkets.com/research/vnnhzv/spanish_tumor) has announced the addition of the "Spanish Tumor Marker Testing Market 2014: Innovations, Trends and Opportunities for Suppliers" report to their offering.
Highlights
Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
Five-year test volume and sales forecasts over for 40 tumor marker performed in Spanish hospitals, commercial laboratories and physician offices.
Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers.
Sales and market shares of leading suppliers. Emerging diagnostic technologies and their potential market applications.
Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunities and strategic recommendations for suppliers.
Contains 565 pages and 85 tables
For more information visit http://www.researchandmarkets.com/research/vnnhzv/spanish_tumor
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.